Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells (Q33385308)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells |
scientific article |
Statements
1 reference
Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells (English)
1 reference
M Lioznov
1 reference
J El-Cheikh
1 reference
F Hoffmann
1 reference
Y Hildebrandt
1 reference
F Ayuk
1 reference
C Wolschke
1 reference
D Atanackovic
1 reference
G Schilling
1 reference
A Badbaran
1 reference
U Bacher
1 reference
A R Zander
1 reference
D Blaise
1 reference
M Mohty
1 reference
N Kröger
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference